TACSTD2 and neoplasm: The observation that GSE1 is upregulated, while TACSTD2 is downregulated, in PCa, with an increased GSE1/TACSTD2 expression ratio defining patients with PCa (Figure 1), is not logically decoupled from the current dysregulated oncogene–tumor suppressor homeostasis paradigm associated with tumor initiation and progression.